Shares of OraSure Technologies Inc. (NASDAQ:OSUR) have been assigned an average rating of “Buy” from the eight brokerages that are presently covering the company. Three analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $8.80.

Several research analysts recently commented on OSUR shares. Zacks Investment Research cut OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, May 25th. Raymond James Financial Inc. cut OraSure Technologies from an “outperform” rating to a “market perform” rating and set a $8.00 price target for the company. in a research report on Monday, June 13th. BTIG Research reissued a “buy” rating and set a $9.00 price target on shares of OraSure Technologies in a research report on Wednesday, June 29th. Mizuho reissued an “outperform” rating and set a $8.00 price target on shares of OraSure Technologies in a research report on Tuesday, July 5th. Finally, TheStreet cut OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 1st.

In related news, Director Charles W. Patrick sold 17,483 shares of OraSure Technologies stock in a transaction that occurred on Wednesday, August 31st. The stock was sold at an average price of $8.58, for a total transaction of $150,004.14. Following the completion of the sale, the director now directly owns 77,209 shares of the company’s stock, valued at approximately $662,453.22. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Jack E. Jerrett sold 68,686 shares of OraSure Technologies stock in a transaction that occurred on Tuesday, August 30th. The stock was sold at an average price of $8.52, for a total value of $585,204.72. Following the sale, the senior vice president now directly owns 86,441 shares of the company’s stock, valued at $736,477.32. The disclosure for this sale can be found here. 7.80% of the stock is owned by insiders.

Hedge funds have recently added to or reduced their stakes in the company. Walleye Trading LLC boosted its stake in OraSure Technologies by 61.9% in the second quarter. Walleye Trading LLC now owns 18,300 shares of the company’s stock valued at $108,000 after buying an additional 7,000 shares during the last quarter. Springbok Capital Management LLC raised its position in OraSure Technologies by 126.7% in the first quarter. Springbok Capital Management LLC now owns 16,300 shares of the company’s stock worth $118,000 after buying an additional 9,110 shares during the period. Janney Montgomery Scott LLC raised its position in OraSure Technologies by 3.2% in the second quarter. Janney Montgomery Scott LLC now owns 18,824 shares of the company’s stock worth $121,000 after buying an additional 579 shares during the period. Los Angeles Capital Management & Equity Research Inc. bought a new position in OraSure Technologies during the first quarter worth approximately $127,000. Finally, Shikiar Asset Management Inc. raised its position in OraSure Technologies by 28.6% in the second quarter. Shikiar Asset Management Inc. now owns 22,500 shares of the company’s stock worth $133,000 after buying an additional 5,000 shares during the period. 79.65% of the stock is owned by institutional investors and hedge funds.

OraSure Technologies (NASDAQ:OSUR) traded up 1.20% during mid-day trading on Wednesday, hitting $8.45. The stock had a trading volume of 381,918 shares. The firm has a market capitalization of $469.82 million, a price-to-earnings ratio of 40.24 and a beta of 1.25. OraSure Technologies has a one year low of $4.39 and a one year high of $9.05. The stock’s 50 day moving average price is $7.82 and its 200 day moving average price is $7.17.

OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.05 by $0.02. OraSure Technologies had a return on equity of 7.60% and a net margin of 10.08%. The firm earned $31.36 million during the quarter, compared to analysts’ expectations of $31.15 million. During the same period in the prior year, the firm posted $0.03 earnings per share. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. Analysts forecast that OraSure Technologies will post $0.27 EPS for the current year.

About OraSure Technologies

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

5 Day Chart for NASDAQ:OSUR

Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.